Solazyme Taps Michael S. Golembieski as Senior Vice President & General Manager of Nutritionals

Solazyme, Inc., a renewable oil and bioproducts company using algal biotechnology, welcomes Michael S. Golembieski to the management team as Senior Vice President and General Manager of Nutritionals. Golembieski will be responsible for growing Solazyme's global food and feed ingredient business for renewable oils, purified microalgae, and microalgae extracts.

"Mike brings decades of strategy and business development experience in the biotechnology, pharmaceutical, and specialty chemicals markets. His prior involvement with such household names as SPLENDA(R) Sucralose demonstrates that he will undoubtedly be an asset to our team as we build our renewable food products business," said Jonathan Wolfson, Chief Executive Officer of Solazyme.

Golembieski is a recognized growth and development expert in the biotechnology and renewable food industries, most recently leading strategy and business development for the SPLENDA(R) Sucralose ingredient business of Tate & Lyle, PLC. He has spent more than 30 years in finance, business and strategy development; successfully initiating and managing acquisitions ranging from $10 to $100 million in total revenue. He brings additional knowledge and skill in intellectual property portfolio management, market development, and manufacturing platform optimization.

"Solazyme is leading the advancement of biofuels, and the company has a vision to harness the power of algae for fuel, food and life. We are making a substantial impact not only in energy and fuel, but also in human and animal nutrition. I look forward to leading this team as we transform the dynamics of nourishing, sustainable and natural food products," said Golembieski.

Prior to working in the SPLENDA(R) Sucralose division of Tate & Lyle, Golembieski spent four years at Apath, L.L.C. as the Vice President of Finance and Business Development for this early-stage biotechnology company engaged in antiviral drug discovery and technology licensing. Before that he spent 21 years at Mallinckrodt, Inc., holding an array of increasingly senior positions in business and strategy development for the company's medical imaging and respiratory product areas. Golembieski holds a B.S. in business administration from the University of Missouri, St. Louis, and is a certified public accountant.

About Solazyme:

Solazyme, Inc. is a renewable oil and bioproducts company and the leader in algal biotechnology. Founded in 2003 and headquartered in South San Francisco, Solazyme's unique technology allows algae to produce oil and biomaterials in standard fermentation facilities quickly, efficiently and at large scale. These oils and biomaterials are tailored not only for biofuel production, but also as replacements for fossil petroleum and plant oils in a diverse range of products running from clean fuels and chemicals to cosmetics and foods. Solazyme's oils and fuels provide compelling solutions to increasingly complex issues of fuel scarcity, energy security and environmental impact while fitting cleanly into the pre-existing multi-trillion dollar fuel infrastructure. Solazyme's investors among others include Braemar Energy Ventures, Harris & Harris Group, Lightspeed VenturePartners, The Roda Group, and VantagePoint Venture Partners. For more information, please visit our website:

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.